Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HIV families get boost from resilience training in new study

NCT ID NCT06340698

Symptom relief Sponsor: City University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether two short training sessions on resilience and medication adherence could improve the quality of life for 130 HIV-positive mothers and their children in China. The training focused on coping skills, stigma management, and communication. Researchers measured changes in mental health, resilience, and medication adherence over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
resilience and adherence behavioral training
What this could lead to
If it works, this could point toward a low-cost way to improve mental health and medication adherence for families living with HIV.
What could go wrong
This is a small, completed trial with only 130 participants, so results may not apply to other groups. The intervention is behavioral, so effects may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

130 people

The number who actually took part.

Started

Jul 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. the child is HIV positive and perinatally infected, and receives HAART; 2. the biological mother of the child is HIV positive and receives HAART; 3. the mother is a primary caregiver of the child. Exclusion Criteria: 1. cannot complete the assessment due to a low education level or physical constraints; 2. have been diagnosed with another life-threatening disease (e.g., cancer); 3. have experienced a traumatic event (e.g., a severe car accident or bereavement) in the past 12 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congenital human immunodeficiency virus HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV Perinatal HIV infection

Contacts and locations

Locations

  • Guangxi Center for Disease Prevention and Control

    Nanning, Guangxi, 530027, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.